Travoprost: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Travoprost. Educational only — not medical advice.
Labeled uses
iDose® TR (travoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Source: FDA labeling via NIH DailyMed (set 92f6d3e2…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.